EP0545000A1 - An improved vessel for perfusion liquids - Google Patents
An improved vessel for perfusion liquids Download PDFInfo
- Publication number
- EP0545000A1 EP0545000A1 EP92114011A EP92114011A EP0545000A1 EP 0545000 A1 EP0545000 A1 EP 0545000A1 EP 92114011 A EP92114011 A EP 92114011A EP 92114011 A EP92114011 A EP 92114011A EP 0545000 A1 EP0545000 A1 EP 0545000A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- vessel
- tube
- perfusion liquids
- improved
- containing perfusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
Definitions
- This invention refers to an improved vessel for containing perfusion liquids offering important novel characteristics in its utilization with respect to currently known vessels used for this purpose.
- Perfusion liquid containers are used generally for the various types of fluids destined for perfusion or injection in the human body, their particular requirement being that they should contain the said fluid under sterile conditions which condition must be maintained up to the moment of the application of the fluid in a clinical operation.
- This invention refers to an improved perfusion liquid vessel having important advantages as against existing containers in that the requirement for sterile enclosures for sterilizing the liquid to be contained in the vessel is no longer necessary (or even in the absence of this requirement ), sterility is maintained up to the moment of use and an automatic control system can be applied to ensure that the procedure has been correct.
- the vessel which is the object of this invention is characterized by having built therein a tube for filling the vessel and which tube has integral with it and inalienable thereto a sterilizing membrane filter with a porosity of between 0,20 and 0,25 microns, for preference being 0,22 microns maximum, such that filling the vessel is coincident with a sterilization action and then, having filled the vessel, given the considerable capilliary force exercised in passages of this fineness, air flow is prevented unless the pressure attains some 3 bars, this phenomenum permitting verification and eventually the integrity and correct operation of the filter.
- Figure 1 shows a frontal view of the vessel in its vertical position.
- Figure 2 is a cross sectional view on the plane so indicated in figure 1.
- Figure 3 shows the detail of the filling tube assembly with its incorporated filter in cross-section.
- Figure 4 is a cross sectional view on the plane so indicated in figure 3.
- Figure 5 is a cross sectional view on the plane so indicated in figure 3.
- this invention is characterized in that it comprises a vessel -1-, made of a synthetic material that is clinically compatible having a flattened form generally, the front and rear faces -2- and -3- respectively being generally planar with the upper and lower zones -4- and -5- being formed with half round or similar ribbing or projections so as to provide an adequate stiffness and strength to those areas.
- the upper zone -5- has incorporated therein the filling tube -6- with the sterilization filter -7- in its upper part, integral with it and forming part of the inviolable system of a non-detachable assembly.
- the filter has a porosity of between 0,20 and 0,25 microns, but preferably not exceeding 0,22 microns such that the vessel can be filled with the perfusion fluid through the tube -6- while the fluid's passage through the filter -7- effects its sterilization and thereafter this same filter with its above dimensioned pores operates as a stopper or closure in that for air to infiltrate through it a pressure of some 3 bars would have to be applied, this feature also providing an effective control by which the sterilizing characteristic of the filter may be monitored.
- the vessel is also provided with an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube.
- an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube.
- Figure 3 shows the filter -7- as having two flat components -12- and -13- joined together by welding or pressing, the piece -13- having as part of it the filler tube -14- and the piece -12- being extended by a tubular connection -15- for attachment by welding or adhesive to the upper end of the tubular component -6-.
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
- This invention refers to an improved vessel for containing perfusion liquids offering important novel characteristics in its utilization with respect to currently known vessels used for this purpose.
- Perfusion liquid containers are used generally for the various types of fluids destined for perfusion or injection in the human body, their particular requirement being that they should contain the said fluid under sterile conditions which condition must be maintained up to the moment of the application of the fluid in a clinical operation.
- Current practice is to sterilize the vessel which already contains the fluid for therapeutic use should the fluid be able to tolerate this procedure or in the contrary case, to sterilize the vessel prior to its filling and then carry out the filling operation in a sterile enclosure so as to preserve the required sterile condition of the fluid to be fed into the vessel and that of the vessel itself.
- This invention refers to an improved perfusion liquid vessel having important advantages as against existing containers in that the requirement for sterile enclosures for sterilizing the liquid to be contained in the vessel is no longer necessary (or even in the absence of this requirement ), sterility is maintained up to the moment of use and an automatic control system can be applied to ensure that the procedure has been correct.
- Essentially, the vessel which is the object of this invention is characterized by having built therein a tube for filling the vessel and which tube has integral with it and inalienable thereto a sterilizing membrane filter with a porosity of between 0,20 and 0,25 microns, for preference being 0,22 microns maximum, such that filling the vessel is coincident with a sterilization action and then, having filled the vessel, given the considerable capilliary force exercised in passages of this fineness, air flow is prevented unless the pressure attains some 3 bars, this phenomenum permitting verification and eventually the integrity and correct operation of the filter. This effect facilitates the control of the filter's correct operation since due to the surface tension in the fine passages of the filter the above pressure is required to overcome this tension and allow air to infiltrate the vessel. Hence after the operation of filling the vessel, in order to check the filter effectiveness an air pressure is applied equivalent to the surface tension produced in the filter and at that point no bubbles should be observed forming in the vessel. This bubble point, measured by the air pressure that the filter is resisting presents a simple method for determining the integrity of filter itself.
- To assist the explanation explanatory drawings are attached showing one embodiment, by way of example, of a liquid perfusion vessel in accordance with this present invention.
- Figure 1 shows a frontal view of the vessel in its vertical position.
- Figure 2 is a cross sectional view on the plane so indicated in figure 1.
- Figure 3 shows the detail of the filling tube assembly with its incorporated filter in cross-section.
- Figure 4 is a cross sectional view on the plane so indicated in figure 3.
- Figure 5 is a cross sectional view on the plane so indicated in figure 3.
- As can be seen in the drawings this invention is characterized in that it comprises a vessel -1-, made of a synthetic material that is clinically compatible having a flattened form generally, the front and rear faces -2- and -3- respectively being generally planar with the upper and lower zones -4- and -5- being formed with half round or similar ribbing or projections so as to provide an adequate stiffness and strength to those areas.
- The upper zone -5- has incorporated therein the filling tube -6- with the sterilization filter -7- in its upper part, integral with it and forming part of the inviolable system of a non-detachable assembly. The filter has a porosity of between 0,20 and 0,25 microns, but preferably not exceeding 0,22 microns such that the vessel can be filled with the perfusion fluid through the tube -6- while the fluid's passage through the filter -7- effects its sterilization and thereafter this same filter with its above dimensioned pores operates as a stopper or closure in that for air to infiltrate through it a pressure of some 3 bars would have to be applied, this feature also providing an effective control by which the sterilizing characteristic of the filter may be monitored.
- The vessel is also provided with an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube. There is also fitted to the upper part of the orifice -8- a further stopper or plug -10- with a tab -11- attached thereto to facilitate its opening but ensuring its closure until the time of its utilization.
- Figure 3 shows the filter -7- as having two flat components -12- and -13- joined together by welding or pressing, the piece -13- having as part of it the filler tube -14- and the piece -12- being extended by a tubular connection -15- for attachment by welding or adhesive to the upper end of the tubular component -6-.
- By means of the above disclosed invention it is acceptable to fill the vessel -1- in surroundings which may not necessarily be sterilized thus simplifying the operation and lessening the cost thereof as well as increasing security. Nevertheless the sterilization both during and after filling is assured by the specific characteristics of the filter preventing the entry of any particles exceeding the dimensions as foreseen for the sterilization effect and at the same time providing an effective impediment to the entry of external air and permitting a monitoring of the filtration effectiveness.
Claims (6)
- An improved vessel for containing perfusion liquids, having a flattened form, closed at one extremity and having at the other extremity an opening for filling the vessel and having also a zone where the syringe or abstraction needle of a catheter feed tube can be inserted, the vessel being characterized in that it is provided with an integral and inviolable wet microfilter preventing the passage of air under atmospheric pressure and which permits its correct functioning to be verified without dismantling the sterilized assembly.
- An improved vessel for containing perfusion liquids as in claim 1. characterized in that the microfilter has a porosity of approximately 0,20 to 0,25 microns, preferably with a maximum of 0,22 microns.
- An improved vessel for containing perfusion liquids, as in claim 2, characterized by the filter consisting of two plates mutually joined together with rounded or curved grooving on their mutually facing surfaces, one of the pieces having a filling orifice and the other a connecting member for joining to a tube incorporated within the vessel by means of an adhesive or by welding.
- An improved vessel for containing perfusion liquids as in claim 1, characterized by the provision of a tubular entry parallel to the incorporated tube and having at some intermediate position a closure part of which is a thin diaphragm for the introduction of the syringe or abstraction needle of a catheter feed.
- An improved vessel for containing perfusion liquids as in claim 4, characterized in that the tube through which the fluid is abstracted has at its upper extremity a closure which can be opened manually.
- An improved vessel for containing perfusion liquids as in claim 5, characterized in that the vessel has at its upper part a detachable element having two tubular bodies, one of which can accept the tube for filling the vessel and the other having a diaphragm which can be pierced by the abstraction needle for supply to the catheter and the manually operated closure tab.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES19919103692U ES1019546Y (en) | 1991-12-05 | 1991-12-05 | PERFUSION LIQUID BAG, PERFECTED. |
ES9103692U | 1991-12-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0545000A1 true EP0545000A1 (en) | 1993-06-09 |
EP0545000B1 EP0545000B1 (en) | 1997-10-29 |
Family
ID=8275372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP92114011A Expired - Lifetime EP0545000B1 (en) | 1991-12-05 | 1992-08-17 | An improved vessel for perfusion liquids |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0545000B1 (en) |
JP (1) | JP2622056B2 (en) |
AT (1) | ATE159653T1 (en) |
BR (1) | BR7201541U (en) |
CH (1) | CH687585A5 (en) |
DE (1) | DE69222922T2 (en) |
ES (2) | ES1019546Y (en) |
IT (1) | IT1261651B (en) |
MX (1) | MX64B (en) |
PT (1) | PT100782B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI108514B (en) * | 1993-06-25 | 2002-02-15 | Cusi Lab | Use of polymer membranes in the distribution of pharmaceutical solutions containing quaternary ammonium compounds as preservatives |
ES2070777B1 (en) * | 1993-10-05 | 1995-12-16 | Mejias David Gonzalez | SANITARY CONTAINER FOR URINE ANALYSIS WITH FEMALE ADAPTER. |
DE60217201T2 (en) | 2001-02-28 | 2007-11-08 | Grifols, S.A. | Apparatus for filling containers for pharmaceutical purposes and the like |
CN108473218B (en) | 2016-01-22 | 2019-07-19 | 巴克斯特国际公司 | For producing the method and machine of sterile solution product bag |
NZ743293A (en) | 2016-01-22 | 2019-05-31 | Baxter Healthcare Sa | Sterile solutions product bag |
FI3715632T3 (en) | 2019-03-26 | 2023-06-02 | Grifols Sa | Method for calibrating a peristaltic pump, method for dispensing a quantity of liquid by means of a peristaltic pump and device for producing sterile preparations that can execute said methods |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265242A (en) * | 1979-07-23 | 1981-05-05 | Cohen Milton J | Filter device for injectable fluid |
US4265760A (en) * | 1979-02-26 | 1981-05-05 | Becton Dickinson & Company | Device for dilution and delivery of in vivo chemicals |
EP0116362A2 (en) * | 1983-02-11 | 1984-08-22 | Millipore Corporation | Sterile package for therapeutic composition |
FR2545376A1 (en) * | 1983-05-03 | 1984-11-09 | Sartorius Gmbh | SMALL FILTER FOR GAS FILTRATION |
DE3333283A1 (en) * | 1983-09-15 | 1985-04-18 | Gerhard 3429 Krebeck Lorenz | Treatment system for infusion solutions |
US4906103A (en) * | 1984-05-30 | 1990-03-06 | Ti Kao | Devices and methods for preparing a solution for medicinal purposes |
WO1992012697A1 (en) * | 1991-01-29 | 1992-08-06 | Baxter International Inc. | System for creating at a site, remote from a sterile environment, a parenteral solution |
-
1991
- 1991-12-05 ES ES19919103692U patent/ES1019546Y/en not_active Expired - Lifetime
-
1992
- 1992-08-17 DE DE69222922T patent/DE69222922T2/en not_active Expired - Lifetime
- 1992-08-17 EP EP92114011A patent/EP0545000B1/en not_active Expired - Lifetime
- 1992-08-17 AT AT92114011T patent/ATE159653T1/en not_active IP Right Cessation
- 1992-08-17 ES ES92114011T patent/ES2110457T3/en not_active Expired - Lifetime
- 1992-08-17 PT PT100782A patent/PT100782B/en not_active IP Right Cessation
- 1992-08-18 MX MX9200119U patent/MX64B/en unknown
- 1992-08-26 JP JP4226998A patent/JP2622056B2/en not_active Expired - Fee Related
- 1992-09-07 IT ITMI922073A patent/IT1261651B/en active IP Right Grant
- 1992-09-16 CH CH02918/92A patent/CH687585A5/en not_active IP Right Cessation
- 1992-09-22 BR BR7201541U patent/BR7201541U/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4265760A (en) * | 1979-02-26 | 1981-05-05 | Becton Dickinson & Company | Device for dilution and delivery of in vivo chemicals |
US4265242A (en) * | 1979-07-23 | 1981-05-05 | Cohen Milton J | Filter device for injectable fluid |
EP0116362A2 (en) * | 1983-02-11 | 1984-08-22 | Millipore Corporation | Sterile package for therapeutic composition |
FR2545376A1 (en) * | 1983-05-03 | 1984-11-09 | Sartorius Gmbh | SMALL FILTER FOR GAS FILTRATION |
DE3333283A1 (en) * | 1983-09-15 | 1985-04-18 | Gerhard 3429 Krebeck Lorenz | Treatment system for infusion solutions |
US4906103A (en) * | 1984-05-30 | 1990-03-06 | Ti Kao | Devices and methods for preparing a solution for medicinal purposes |
WO1992012697A1 (en) * | 1991-01-29 | 1992-08-06 | Baxter International Inc. | System for creating at a site, remote from a sterile environment, a parenteral solution |
Also Published As
Publication number | Publication date |
---|---|
PT100782A (en) | 1994-05-31 |
ITMI922073A0 (en) | 1992-09-07 |
CH687585A5 (en) | 1997-01-15 |
MX64B (en) | 1993-08-03 |
ATE159653T1 (en) | 1997-11-15 |
ITMI922073A1 (en) | 1993-06-06 |
DE69222922D1 (en) | 1997-12-04 |
ES1019546Y (en) | 1992-11-01 |
PT100782B (en) | 1999-09-30 |
EP0545000B1 (en) | 1997-10-29 |
ES1019546U (en) | 1992-04-01 |
JPH05212115A (en) | 1993-08-24 |
IT1261651B (en) | 1996-05-28 |
BR7201541U (en) | 1993-08-03 |
JP2622056B2 (en) | 1997-06-18 |
DE69222922T2 (en) | 1998-04-09 |
ES2110457T3 (en) | 1998-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2001198226A (en) | Sterilizing state keeping connection system for medical system, female connection element and male connection element, and method of using sterilizing state keeping connection system for medical system | |
US5219101A (en) | Contamination-resistant dispensing and metering drop forming device | |
US5265770A (en) | Contamination-resistant dispensing and metering device | |
JP3618752B2 (en) | Liquid container with dual-purpose access port | |
JP4533887B2 (en) | Connector for pack containing medical fluid and pack for medical fluid | |
US6345553B1 (en) | Ink application device for tattooing or for making permanent make-up | |
JPH0436704B2 (en) | ||
MXPA06004241A (en) | Connector for medical liquid-containing packages and medical liquid-containing packages. | |
JPH01501920A (en) | Sterile one-piece container and fluid transfer set | |
GB2104044A (en) | Bag and valve assembley for medical use | |
EP0545000A1 (en) | An improved vessel for perfusion liquids | |
DE1087324B (en) | Infusion device | |
JPH08168530A (en) | Insulin injector | |
US5342345A (en) | Solution bag with plastic connecting tube | |
JP2002224195A (en) | Transfusion container | |
DE102008057822B4 (en) | Device for storage and dermal administration of a substance | |
NZ563449A (en) | A line, such as a line of a blood tubing, with plastically deformable closure member in line | |
EP0401022B1 (en) | Contamination-resistant dispensing and metering device | |
US5122126A (en) | Nozzle member provided with sealing membrane | |
JPH0585557A (en) | Cap for distributing liquid from vessel and liquid distributor | |
EP1882486A1 (en) | Device for handling perfusion liquids with membrane filter and anti-tamper means | |
DE2844206A1 (en) | Protective cap for vessel mouth - has disc containing perforation point below removable section of end wall formed integral with cylindrical part of cap housing | |
US6544250B1 (en) | Blind clinical trial device | |
WO1996026701A1 (en) | System for enteral/parenteral administration of a substance | |
EP2756854A1 (en) | Medical fluid bag |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE DE DK ES FR GB NL SE |
|
17P | Request for examination filed |
Effective date: 19931108 |
|
17Q | First examination report despatched |
Effective date: 19950309 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE DE DK ES FR GB NL SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 19971029 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 19971029 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 19971029 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19971029 |
|
REF | Corresponds to: |
Ref document number: 159653 Country of ref document: AT Date of ref document: 19971115 Kind code of ref document: T |
|
REF | Corresponds to: |
Ref document number: 69222922 Country of ref document: DE Date of ref document: 19971204 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19980129 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2110457 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CA |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20101029 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20110610 Year of fee payment: 20 Ref country code: ES Payment date: 20110603 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20110629 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69222922 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R071 Ref document number: 69222922 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20120816 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20120816 Ref country code: DE Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20120818 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20121207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20120818 |